Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

CCO Medical Specialties Podcast

Innhold levert av Clinical Care Options LLC and Clinical Care Options. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Clinical Care Options LLC and Clinical Care Options eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

6M ago 32:19

MP3•Episoder hjem

In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:

Beneficial effects beyond glycemic control
Adverse events and how to manage them
Non- or partial responders and the importance of setting expectations with patients
Weight rebound when discontinuing therapy
Medication access issues related to cost and drug availability

Presenters:

Jennifer Green, MD
Professor of Medicine
Division of Endocrinology and Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina

Carol Hatch Wysham, MD
Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Link to online program:
https://bit.ly/48b6XnW

26 episoder